Hewitt and Harvey
JOCNote
SCHEME 4. Silver-Promoted Ring Expansions of Cyclopro-
pane 1
127.5 (CH), 112.6 (CH), 98.9 (CH), 79.3 (CH), 76.1 (CH), 73.1
(CH2), 71.5 (CH2), 71.4 (CH), 70.8 (CH2), 69.5 (CH2), 55.2
(CH3); IR (KBr) 3054, 3027, 2961, 2865, 1629, 1496, 1453, 1345,
1261, 1094, 1072, 802, 735, 697 cm-1
.
4r: Rf 0.25 (1:9 EtOAc/hexanes); [R]17 þ18 (c 1.0, CHCl3)
D
[lit.8 [R]25D þ26.7 (c 1, CHCl3)]; 1H NMR (500 MHz, CDCl3) δ
7.36-7.24 (complex m, 15H), 6.78 (s, 1H), 5.05 (s, 1H), 4.71
(d, J =11.5 Hz, 1H), 4.69 (d, J = 3.7 Hz, 1H), 4.62 (d, J = 11.7 Hz,
1H), 4.52 (complex m, 2H), 4.50 (d, J = 11.7 Hz, 1H), 4.48
(d, J = 11.7 Hz, 1H), 3.91 (dd, J = 5.0, 3.8 Hz, 1H), 3.85
(m, 1H), 3.83 (dd, J = 10.0, 5.2 Hz, 1H), 3.77 (dd, J = 10.0, 5.1 Hz,
1H), 3.47 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 138.4 (C),
138.3 (C), 137.8 (C), 137.0 (C), 128.4 (CH), 128.33 (CH), 128.25
(CH), 127.9 (CH), 127.8 (CH), 127.7 (CH), 127.56 (CH), 127.55
(CH), 114.7 (CH), 101.1 (CH), 76.0 (CH), 74.9 (CH), 74.6 (CH),
73.3 (CH2), 72.2 (CH2), 70.9 (CH2), 70.6 (CH2), 55.8 (CH3); IR
(KBr) 3060, 3030, 2912, 2865, 1629, 1496, 1453, 1363, 1303,
1205, 1097, 1072, 1027, 818, 735, 697 cm-1; HRMS m/z
C29H31O579BrK [M þ K]þ calcd 577.0992, found 577.0988.
Methyl 3,4,6-Tri-O-benzyl-2-deoxy-2-C-methylene-r-D-ara-
bino-hexopyranoside (5). A solution of bromide 4r (20 mg,
0.037 mmol) in THF (0.5 mL) was cooled to -78 °C and treated
with n-butyllithium (50 μL, 1.6 M in hexanes) and then stirred at
this temperature for 1 h. The reaction mixture was then treated
with water (50 μL), and immediately allowed to warm to room
temperature. After 30 min of additional stirring, the reaction
mixture was diluted with water, then extracted with diethyl
ether. The ethereal fractions were combined, dried, and con-
centrated to provide a colorless oil, which was purified by flash
chromatography (1:9 EtOAc/hexanes) to provide known alkene
514 (5 mg, 29% yield) as a colorless oil: Rf 0.25 (1:9 EtOAc/
hexanes); [R]17 þ13 (c 0.3, CHCl3) [lit.14 [R]25 þ32 (c 1,
in refluxing acetic acid caused extensive decomposition.8
However, optimization of the reaction conditions provided
the anomeric acetates 8r and 8β in 52% yield and a 3.5:1
ratio after treatment with silver(I) acetate in acetic acid at
100 °C (Scheme 4). Replacing the acetic acid with toluene
and adding sodium acetate (5 equiv) to the reaction led to
improved results (65% combined yield, 4.3:1 ratio of 8r
and 8β). The anomeric stereochemistries of the oxepines
8 were tentatively assigned on the basis of an NOE enhance-
ment (ca. 5%) between H1 and H6 in the minor isomer. The
presence of the anomeric acetate provides an opportunity for
the formation of alternative glycosidic linkages. The alkenyl
bromide moiety provides scope for further derivatizations to
a range of septanosides.
In summary, several 2-C-branched pyranosides and
septanoside precursors have been prepared. The product
structures previously reported8 for the reaction of D-glucal-
derived cyclopropane 1 with potassium carbonate in metha-
nol have been revised as 2-C-branched pyranose sugars.
Additionally, conditions involving silver(I) salts that suc-
cessfully produce 2-bromooxepines are provided.
D
D
CH2Cl2)]; 1H NMR (500 MHz, CDCl3) δ 7.40-7.15 (complex
m, 15H), 5.30 (s, 1H), 5.16 (s, 1H), 5.06 (s, 1H), 4.87 (d, J = 10.7
Hz, 1H), 4.76 (d, J = 11.2 Hz, 1H), 4.70 (d, J = 11.2 Hz, 1H),
4.63 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 12.2 Hz, 1H), 4.49 (d, J =
10.7 Hz, 1H), 4.42 (dd, J = 9.0, 2.0 Hz, 1H), 3.92 (ddd, J = 9.9,
3.8, 1.9 Hz, 1H), 3.75 (dd, J = 10.6, 3.9 Hz, 1H), 3.69 (dd, J =
10.6, 1.9 Hz, 1H), 3.60 (t, J = 9.4 Hz, 1H), 3.38 (s, 3H); 13C
NMR (125 MHz, CDCl3) δ 142.3 (C), 138.32 (C), 138.27 (C),
138.1 (C), 128.4 (CH), 128.3 (CH), 127.9 (CH), 127.8 (CH),
127.7 (CH), 127.63 (CH), 127.61 (CH), 110.7 (CH2), 102.4 (CH),
81.2 (CH), 79.9 (CH), 74.9 (CH2), 73.5 (CH2), 73.4 (CH2), 71.5
(CH), 68.8 (CH2), 54.5 (CH3); IR (KBr) 3029, 2907, 1496, 1454,
1359, 1102, 1067, 1026, 968, 736, 697 cm-1; HRMS m/z
C29H32O5Na [M þ Na]þ calcd 483.2147, found 483.2145.
Methyl 4,5,7-Tri-O-benzyl-2-bromo-2,3-dideoxy-r-D-arabi-
no-hept-2-enoseptanoside (3r) and Methyl 4,5,7-Tri-O-benzyl-
2-bromo-2,3-dideoxy-β-D-arabino-hept-2-enoseptanoside (3β). A
solution of cyclopropane 1 (104 mg, 0.177 mmol) in methanol
(1.7 mL) was treated with silver acetate (37 mg, 0.22 mmol) and
refluxed for 5 days in the dark. The reaction mixture was then
diluted with diethyl ether, and filtered through a pad of Celite,
then the ethereal filtrate was washed with water. The aqueous
wash was further extracted with diethyl ether, then the ethereal
solutions were combined, dried (MgSO4), filtered, and concen-
trated to provide a pale-yellow oil. Purification of this crude
product by column chromatography (silica, 1:9 EtOAc/hexanes)
delivered recovered starting material 1 (63 mg, 61%), plus ox-
epines 3β (4 mg, 4%) as a colorless oil and 3r (11 mg, 11%) as a
colorless oil.
Experimental Section
General Procedure for the Synthesis of 2-C-Branched Pyrano-
sides. A solution of sodium alkoxide (ca. 1.5 equiv) in the
corresponding alcohol (ca. 5 equiv), prepared by dissolution
of metallic sodium in the alcohol, was diluted with THF (10 mL/
mmol of cyclopropane). Cyclopropane 1 (1 equiv) was added
and the resulting solution was refluxed until the starting ma-
terial was consumed. The reaction mixture was then cooled,
diluted with water, and extracted with dichloromethane. The
combined organic fractions were dried (MgSO4), filtered, and
concentrated. The crude products were separated with flash
chromatography.
Methyl (2E)-3,4,6-Tri-O-benzyl-2-C-(bromomethylene)-2-deoxy-
r-D-arabino-hexopyranoside (4r) and Methyl (2E)-3,4,6-Tri-O-
benzyl-2-C-(bromomethylene)-2-deoxy-β-D-arabino-hexopyrano-
side (4β). Use of sodium (6.5 mg, 0.3 mmol), methanol (63 μL,
1.6 mmol), THF (1.7 mL), and cyclopropane 1 (100 mg, 0.17
mmol) as described above yielded a yellow oil after 75 min.
Chromatography of this oil (silica, 1:9 EtOAc/hexanes) af-
forded compounds 4β (20 mg, 22%) as a colorless oil and 4r
(45 mg, 49%) as a colorless oil.
4β: Rf 0.35 (1:9 EtOAc/hexanes); [R]17 þ57 (c 1.0, CHCl3)
D
1
[lit.8 [R]25 þ69 (c 2, CHCl3)]; H NMR (500 MHz, CDCl3) δ
D
7.41-7.18 (complex m, 15H), 6.81 (d, J = 1.7 Hz, 1H), 5.19 (d,
J = 1.7 Hz, 1H), 4.73 (d, J = 1.2 Hz, 1H), 4.64 (d, J = 12.2 Hz,
1H), 4.60 (d, J = 12.2 Hz, 1H), 4.52 (d, J = 11.5 Hz, 1H), 4.50
(d, J = 12.2 Hz, 1H), 4.43 (d, J = 12.2 Hz, 1H), 4.29 (d, J = 11.5
Hz, 1H), 3.74 (dd, J = 9.0, 1.5 Hz, 1H), 3.69 (ddd, J = 8.8, 5.1,
2.4 Hz, 1H), 3.65 (dd, J = 10.9, 2.5 Hz, 1H), 3.62 (dd, J = 10.9,
5.3 Hz, 1H), 3.47 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 138.3
(C), 138.1 (C), 137.7 (C), 137.5 (C), 128.32 (CH), 128.27 (CH),
128.0 (CH), 127.9 (CH), 127.8 (CH), 127.72 (CH), 127.67 (CH),
3β: Rf 0.30 (1:9 EtOAc/hexanes); 1H NMR (500 MHz,
CDCl3) δ 7.36-7.15 (complex m, 15H), 6.33 (d, J = 5.1 Hz,
1H), 5.14 (s, 1H), 4.68 (d, J = 12.0 Hz, 1H), 4.65 (d, J = 11.2 Hz,
1H), 4.59 (d, J = 11.7 Hz, 1H), 4.59 (d, J = 12.2 Hz, 1H), 4.51
(d, J = 12.0 Hz, 1H), 4.45 (d, J = 11.2 Hz, 1H), 4.17-
4.14 (complex m, 2H), 3.77 (dd, J = 8.9, 5.7 Hz, 1H), 3.70 (dd,
J = 10.5, 5.6 Hz, 1H), 3.61 (dd, J = 10.5, 2.7 Hz, 1H), 3.46 (s, 3H);
J. Org. Chem. Vol. 75, No. 3, 2010 957